GP-Leds

In the minds of managers

CFOs of private markets managers discussed at a recent event the challenges – and opportunities – they face in light of the explosive growth of the secondaries market.

Lexington bulks up leadership on secondaries investment committee

The New York-headquartered firm also promoted two employees to partner.

Inflexion shops $2bn-plus European multi-asset continuation fund

The mid-market manager is seeking to move four assets into a new vehicle, Secondaries Investor has learned.

Manulife secondaries co-heads to depart the firm

Paul Sanabria and Jeff Hammer joined the asset management unit of Canada’s largest insurer in 2019 and have overseen its debut GP-led fundraise.

Graham Partners runs single-asset deal on Gatekeeper Systems

While some believe exit activity will pick up this year along with overall investment activity, PE-backed assets held in older funds continue to grow.

Secondaries deals are on the cards for Australia’s Aware Super

The fund, which manages around $110bn on behalf of nurses and teachers, is heading towards its private markets allocation targets after a period of build-up and growth. In this podcast, Deputy CIO Damien Webb discusses the fund’s view of the secondaries market.

TPG Angelo Gordon runs $1.5bn-plus GP-led credit secondaries process

The process comes at a time of increased momentum for GP-led credit deals with a number $1bn-plus transactions closing last year.

Majority of GPs plan to use secondaries market over coming two-year period – PJT

Over 75% of manager respondents say it is likely or highly likely they’ll look to the secondaries market across 2025 and 2026 compared with 45% in PJT’s 2023 survey.

Six CV missteps and how to avoid them

There are parallels between today’s secondaries market and the M&A market at large, writes Jonathan Graham, Lincoln International’s head of private funds advisory Europe.

Single-asset deals skyrocketed in 2024 – Campbell Lutyens

Volume from single asset deals grew by more than 80% year-on-year, accounting for more than half of all GP-led deal volume in 2024, according to Campbell Lutyens’ full-year secondaries report.